• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

PharmaCyte Biotech, Inc. - Common Stock (NQ:PMCB)

0.3402 -0.0172 (-4.81%)
Delayed Quote Updated: 3:58 PM EDT, Oct 16, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 32,984
Open 0.3500
Bid (Size) 0.3397 (100)
Ask (Size) 0.3799 (100)
Prev. Close 0.3574
Today's Range 0.3401 - 0.3613
52wk Range 0.3339 - 1.510
Shares Outstanding 10,134,160
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Wondering what's happening in today's after-hours session? ↗
January 15, 2026
Via Chartmill
News headline image
On Friday, there are stocks with unusual volume. Let's take a look. ↗
December 05, 2025
The trading volume of these stocks is deviating from the norm in today's session. 
Via Chartmill

Performance

52-Week Range 77.5% below 52-week high
0.3402
0.3352W Low 1.5152W High
1 Week 14.1% below 1-week high
0.341W Low 0.401W High

PharmaCyte Biotech, Inc. - Common Stock (PMCB) traded between $0.33 and $1.51 over the past 52 weeks and last traded at $0.34, 77.5% below its 52-week high. Over the past week it ranged between $0.34 and $0.40.

Past 12 Months
-6.8%
-26.0%
-45.4%
-55.5%
-53.9%
-65.3%
1W -$0.02
1M -$0.12
3M -$0.28
6M -$0.42
YTD -$0.40
1Y -$0.64

PMCB was -65.3% over the past year, -55.5% over six months, -53.9% year to date, -6.8% in the last week.

12 Months vs Market
PMCB
-65.3%
DIA
+11.2%
SPY
+13.7%
QQQ
+16.1%
IWM
+9.0%

Over the past 12 months PMCB returned -65.3% versus DIA (Dow) +11.2%, SPY (S&P 500) +13.7%, QQQ (Nasdaq 100) +16.1% and IWM (Russell 2000) +9.0%.

Volume & Liquidity 0.16× 3-mo avg
Today 32,984 3-mo avg 204.1K
1W
62.0K
1M
152.0K
3M
204.1K
6M
188.5K
YTD
197.6K
1Y
992.1K

PMCB most recently traded 32,984 shares against a 3-month average daily volume of 204.1K.

More News

Read More
News headline image
Keep an eye on the top gainers and losers in Thursday's session. ↗
December 04, 2025
Via Chartmill
News headline image
Which stocks are most active on Thursday? ↗
December 04, 2025
Via Chartmill
News headline image
PMCB Stock Earnings: PharmaCyte Biotech Reported Results for Q3 2024 ↗
March 19, 2024
Via InvestorPlace
News headline image
Let's take a look at the stocks that are in motion in today's session. ↗
December 04, 2025
Via Chartmill
News headline image
Gapping stocks in Thursday's session ↗
December 04, 2025
Via Chartmill
News headline image
Get insights into the top gainers and losers of Tuesday's after-hours session. ↗
November 25, 2025
Via Chartmill
News headline image
PMCB Stock Jumps 25% After Company Sells Stake In Femasys ↗
November 25, 2025
Via Stocktwits
News headline image
PharmaCyte Biotech Successfully Monetizes Femasys Stake, Strengthening Cash Position and Underscoring Strategic Capital Deployment
November 25, 2025
From PharmaCyte Biotech, Inc.
Via Business Wire
News headline image
PharmaCyte Biotech, Inc. Increases Stake in TNF Pharmaceuticals Around Recent License for Breakthrough Light Speed Computing Platform for Use in Cryptocurrency Applications
September 02, 2025
From PharmaCyte Biotech, Inc.
Via Business Wire
News headline image
PharmaCyte Biotech, Inc. Announces Closing of $7 Million Financing
August 20, 2025
From PharmaCyte Biotech, Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
August 19, 2025
Via Benzinga
News headline image
PharmaCyte Biotech, Inc. Announces $7 Million Capital Raise Led by Existing Investors
August 18, 2025
From PharmaCyte Biotech, Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
May 27, 2025
Via Benzinga
News headline image
PharmaCyte Biotech Makes $7 Million Strategic Investment in MyMD, A Biopharmaceutical Company Focused on Inflammatory Disease
May 21, 2024
From PharmaCyte Biotech, Inc.
Via Business Wire
News headline image
PMCB Stock Earnings: PharmaCyte Biotech Reported Results for Q2 2024 ↗
December 18, 2023
Via InvestorPlace
News headline image
PharmaCyte Biotech Acquires $5 Million Stake in Emerging Women’s Health Innovator Femasys, Inc.
November 15, 2023
From PharmaCyte Biotech, Inc.
Via Business Wire
News headline image
Femasys Inc. Secures Additional Financing with Strategic Investment from Investors led by PharmaCyte Biotech
November 15, 2023
From Femasys Inc.
Via GlobeNewswire
News headline image
PharmaCyte Biotech Provides Corporate Update on Cell-in-a-Box Technology
October 31, 2023
From PharmaCyte Biotech, Inc.
Via Business Wire
News headline image
PharmaCyte Biotech Announces Final Results of Tender Offer
June 15, 2023
From PharmaCyte Biotech, Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
May 11, 2023
Via Benzinga
News headline image
PharmaCyte Biotech Announces Cash Tender Offer for up to 7,750,000 Shares at $3.25 Per Share
May 11, 2023
From PharmaCyte Biotech, Inc.
Via Business Wire
News headline image
Stocks That Hit 52-Week Lows On Tuesday ↗
September 26, 2023
Via Benzinga
News headline image
PharmaCyte Biotech to Implement Second $10-Million Share Repurchase Plan
February 02, 2023
From PharmaCyte Biotech, Inc.
Via Business Wire

Frequently Asked Questions

Is PharmaCyte Biotech, Inc. - Common Stock publicly traded?
Yes, PharmaCyte Biotech, Inc. - Common Stock is publicly traded.
What exchange does PharmaCyte Biotech, Inc. - Common Stock trade on?
PharmaCyte Biotech, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for PharmaCyte Biotech, Inc. - Common Stock?
The ticker symbol for PharmaCyte Biotech, Inc. - Common Stock is PMCB on the Nasdaq Stock Market
What is the current price of PharmaCyte Biotech, Inc. - Common Stock?
The current price of PharmaCyte Biotech, Inc. - Common Stock is 0.3402
When was PharmaCyte Biotech, Inc. - Common Stock last traded?
The last trade of PharmaCyte Biotech, Inc. - Common Stock was at 10/16/26 03:58 PM ET
What is the market capitalization of PharmaCyte Biotech, Inc. - Common Stock?
The market capitalization of PharmaCyte Biotech, Inc. - Common Stock is 3.45M
How many shares of PharmaCyte Biotech, Inc. - Common Stock are outstanding?
PharmaCyte Biotech, Inc. - Common Stock has 3M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap